This test is part of AmbrySCREEN Version 2™, a targeted mutation panel. Common mutations associated with the following conditions are included on this panel.
This test is part of AmbrySCREEN Version 2™, a targeted mutation panel. Common mutations associated with the following conditions are included on this panel.
Guanidinoacetate Methyltransferase deficiency is characterized by severe intellectual disability, therapy-resistant epilepsy, and movement disorders including chorea and ataxia.
Specific mutation analysis of p.K109K, p.W20S on the GAMT gene.